Cargando…

Gonadotropin Suppression for 7 Years After a Single Histrelin Implant for Precocious Puberty

Gonadotropin-releasing hormone analogues (GnRHas) are an effective treatment to address the compromise in height potential seen in patients with central precocious puberty. There is no evidence in the literature of a single GnRHa used for longer than 2 years before being removed or replaced. We desc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villalta, Douglas, Quintos, Jose B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758400/ https://www.ncbi.nlm.nih.gov/pubmed/35047716 http://dx.doi.org/10.1210/jendso/bvab189

Ejemplares similares

Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
por: Lewis, Katherine A, et al.
Publicado: (2009)

Results of a Second Year of Therapy with the 12-Month Histrelin Implant for the Treatment of Central Precocious Puberty
por: Rahhal, Samar, et al.
Publicado: (2009)

Precocious puberty due to human chorionic gonadotropin secreting germinoma
por: Nascimento, Daiane J., et al.
Publicado: (2012)

Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
por: Kim, Han Kyul, et al.
Publicado: (2011)

Leydig Cell Tumor-Induced Gonadotropin-Independent Precocious Puberty Progressing to Gonadotropin-Dependent Precocious Puberty Post Orchiectomy: Out of the Frying Pan Into the Fire
por: Singhania, Pankaj, et al.
Publicado: (2022)

SAT-298 A Case of a Forgotten Histrelin Acetate Implant: Can Histrelin Acetate Implants Be Used for More Than a Year?
por: KV Krishnaraj, Balasundari, et al.
Publicado: (2019)

Gonadotropin-Dependent Precocious Puberty: Neoplastic Causes and Endocrine Considerations
por: Stephen, Matthew D, et al.
Publicado: (2011)

The genes associated with gonadotropin-releasing hormone-dependent precocious puberty
por: Hwang, Jin Soon
Publicado: (2012)

Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty
por: Kang, Eungu, et al.
Publicado: (2016)

Normal Adult Height in an Untreated Boy With McCune-Albright Syndrome Presenting With Precocious Puberty
por: Lhamu, Ugen, et al.
Publicado: (2023)

Extended Use of Histrelin Implant in Pediatric Patients
por: Pine-Twaddell, Elyse, et al.
Publicado: (2023)

Idiopathic central precocious puberty in a Klinefelter patient: highlights on gonadotropin levels and pathophysiology
por: Maqdasy, Salwan, et al.
Publicado: (2020)

Histrelin Implants for Suppression of Puberty in Youth with Gender Dysphoria: A Comparison of 50 mcg/Day (Vantas) and 65 mcg/Day (SupprelinLA)
por: Olson-Kennedy, Johanna, et al.
Publicado: (2021)

Clinical data and basal gonadotropins in the diagnosis of central precocious puberty in girls
por: Durá-Travé, Teodoro, et al.
Publicado: (2021)

Hepatoblastoma with Precocious Puberty
por: Yhoshu, Enono, et al.
Publicado: (2019)

A Case of Nonalcoholic Steatohepatitis in Central Precocious Puberty Aggravated by Gonadotropin-releasing Hormone Analog
por: Sasaki, Yoshiaki, et al.
Publicado: (2020)

Single random measurement of urinary gonadotropin concentration for screening and monitoring girls with central precocious puberty
por: Lee, Se Young, et al.
Publicado: (2021)

Challenges and controversies in diagnosis and management of gonadotropin dependent precocious puberty: An Indian perspective
por: Kumar, Manoj, et al.
Publicado: (2015)

The value of urinary gonadotropins in the diagnosis of central precocious puberty: a meta-analysis
por: Xu, Dan, et al.
Publicado: (2022)

Commentary on "Single random measurement of urinary gonadotropin concentration for screening and monitoring girls with central precocious puberty"
por: Kwon, Ahreum
Publicado: (2021)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
por: Kim, Hye Ryun, et al.
Publicado: (2017)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
por: Yoon, Jong Wan, et al.
Publicado: (2017)

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
por: Popovic, Jadranka, et al.
Publicado: (2022)

Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty
por: Shim, Young Suk, et al.
Publicado: (2020)

Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty
por: Kwon, Eun Byul, et al.
Publicado: (2015)

Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
por: Yang, Eun Hye, et al.
Publicado: (2023)

The Gonadotropin-Releasing Hormone Analogue Therapy May Not Impact Final Height in Precocious Puberty of Girls With Onset of Puberty Aged 6 - 8 Years
por: Korkmaz, Ozlem, et al.
Publicado: (2019)

Precocious puberty in girls
por: Chittwar, Sachin, et al.
Publicado: (2012)

Precocious puberty in children
por: Atta, Irum, et al.
Publicado: (2013)

Management of precocious puberty
por: Tanaka, Toshiaki
Publicado: (2013)

Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
por: Choi, Min-Seon, et al.
Publicado: (2016)

Transient Arterial Hypertension Induced by Gonadotropin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Sifaki, Loukia, et al.
Publicado: (2019)

Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty: a mini review
por: Ab Rahim, Siti Nadirah, et al.
Publicado: (2020)

Clinical and Laboratory Parameters of Gonadotropin-Releasing Hormone Analog Treatment Effectiveness in Children with Precocious Puberty
por: Fujita, Lívia Grimaldi Abud, et al.
Publicado: (2019)

Correction to: The Gonadotropin-Releasing Hormone Analogue Therapy May Not Impact Final Height in Precocious Puberty of Girls With Onset of Puberty Aged 6 - 8 Years
por: Korkmaz, Ozlem, et al.
Publicado: (2019)

Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty
por: Lee, Ji Woo, et al.
Publicado: (2014)

Commentary on "Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty"
por: Kwon, Ahreum
Publicado: (2023)

A Matter of Time: Delayed Presentation and Rapid Progression from Gonadotropin-Independent to Gonadotropin-Dependent Precocious Puberty following Successful Treatment for a Leydig Cell Tumor
por: Naotunna, C. R., et al.
Publicado: (2022)

Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience
por: Swendiman, Robert A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7obpu7rom2a0te0qm5k3uvnee0